United States Pediatric Vaccine market is
likely to reach nearly US$ 10 Billion by 2024.
Growth in US pediatric vaccine market can
be attributed to factors such as increased disease awareness, growing public
acceptance, increasing government focus on immunization programs and increased
government funding for the vaccine development.
The research report titled “United States
Pediatric Vaccine Market 2017 – Demand, Insights, Analysis, Opportunities
Segmentation and Forecast to 2024” examines the market dynamics, competitive
landscape and discusses major trends. The study describes an in–depth analysis
of the United States pediatric vaccine market.
The report contains a granular analysis of
the market segmentation, reveal facts on the market size, volume and revenues
and provides forecasts through 2024. The report also provides a deep and
thorough evaluation of the top 10 pediatric vaccines by disease indication. On
the basis of disease indication, the top 10 pediatric vaccines provide an
in-depth analysis of doses administered, number of children being vaccinated
and market size. The report also explores detailed description of growth
drivers and inhibitors of the United States pediatric vaccine market.
The report concludes with the profiles of
major players in the United States pediatric vaccine market. The key market
players are evaluated on various parameters such as company overview, pediatric
vaccine portfolios and latest development & trends of the pediatric vaccine
market.
Major
Pediatric Vaccines (Disease Indication) Covered Under This Report Are:
- Diphtheria, Tetanus & Pertussis (DTap)
- Hepatitis A
- Varicella/Chicken Pox
- Pneumococcal
- Haemophilus Influenzae Type B (HIB)
- Polio
- Rotavirus
- Hepatitis B
- Influenza Pediatric
- Measles, Mumps & Rubella (MMR)
Key
Companies Covered in the Report are as follows:
- Sanofi Pasteur
- GlaxoSmithKline(GSK)
- Merck & Co.
- Pfizer Inc
- Grifols
Key
Deliverables in the Study
- Market Definition for the specified topic along with identification of key drivers and inhibitors for the market
- It provides a growth map over time to understand the industry growth rate
- It provides a seven-year forecast assessed based on how the market is predicted to grow
- It helps in understanding the key product segments and their future
- It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments
- A comprehensive list of key market players along with the analysis of their current pediatric vaccines portfolios and latest development and trends.
Spanning over 115 pages “United
States Pediatric Vaccine Market 2017 - Demand, Insights, Analysis,
Opportunities Segmentation and Forecast to 2024” report covers Executive
Summary, Market Size & Analysis: United States Pediatric Vaccine (2010 –
2024), United States Pediatric Vaccine Market Share and Y–o–Y Growth (%), Key
Market Drivers and Inhibitors of the United States Pediatric Vaccine Market,
United States Pediatric Vaccine Market - By Disease Indication (2010 - 2024),
Key Companies Analysis.
Please visit this link for more details: http://mrr.cm/UUx
Find all Pharma
and Healthcare Reports at: https://www.marketresearchreports.com/pharma-healthcare
No comments:
Post a Comment
Note: only a member of this blog may post a comment.